By: Michelle McMurry-Heath, MD, Ph.D. Women differ from men in anatomy, physiology, risk factors and disease symptoms. They are also likely to use more medical devices over the course of their lives than men do. That is why FDA is … Continue reading →
By: David G. White, Ph.D. It’s an impressive sight – 161 posters representing the work of FDA scientists involved in researching food safety and animal health. This third annual food and veterinary science conference taking place at FDA yesterday and … Continue reading →
The U.S. Food and Drug Administration (FDA) is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare and serious brain infection after taking the drug Gilenya (fingolimod).
